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Stenting for carotid artery stenosis: Fractures,
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Tarun Gandhi, MS (Gen Surg), FVES (India), and Kishore Sieunarine, FRACS, FRCSE, DDU,
Perth, Western Australia, Australia
Purpose: Carotid artery stenting is a relatively new intervention for the treatment of carotid artery stenosis, and the
long-term outcomes and complications are therefore yet to be determined. In one surgeon’s practice, it was found that a
stent fracture was the etiological factor for recurrent stenosis. A retrospective study was therefore performed with the
hypothesis that carotid stent fractures are common. The aims were to determine prevalence of fractures in this surgeon’s
series, risk factors, and most importantly, clinical relevance.
Methods: Patients from one surgeon’s private practice who had carotid stenosis deemed suitable for intervention (>80%
asymptomatic, >70% symptomatic, 50% to 70% if an ulcerated lesion) and had suitable aortic and carotid morphology for
carotid stenting between March 2004 and December 2006 were included. To enhance the quality of the measurement,
two vascular surgeons and one radiologist examined the films independently to determine if there was a fracture present.
Given that this was a retrospective study, there was no preconceived sample size determined.
Results: Fracture prevalence was found to be 29.2% or 14 out of 48 stents. Restenosis occurred in 21% of those stents with
a detected fracture, after an average follow-up of 15 months. Several anetiological factors are proposed, with a finding in
this series, of a strong and significant association between the presence of calcified vessels and the presence of fractures
(odds ratio 7.7; standard error 5.6; 95% confidence interval 1.9-32.0, P .003).
Conclusions: Although this is a small study, it demonstrates that carotid stent fractures do exist, and importantly, not all
of them are benign. Therefore, the authors recommend regular surveillance with plain radiography in addition to duplex
ultrasonography to enable early detection of fracturing. Following detection, institution of increased surveillance
frequency and/or any appropriate intervention can be implemented, to aid in the prevention of complications resulting
from restenosis should it become apparent. ( J Vasc Surg 2008;47:1220-6.)Carotid endarterectomy (CEA) is the current gold
standard for the management of patients with high-grade
carotid stenoses, being superior to best medical therapy, as
established by several landmark-randomized trials.1-3
However, since the first successful CEA by DeBakey in
1953, an alternative therapy has emerged during the last
decade that has created new controversy – carotid artery
stenting (CAS). This technique is reported to avoid certain
complications of endarterectomy such as cranial nerve in-
jury, wound complications, and discomfort of open sur-
gery. However, CAS is not without its own complications.
The index case that prompted this series4 was noted
accidentally during the deployment of a contralateral stent.
The residual stenosis post-deployment was less than 10%. A
6-month surveillance scan of the stented side showed a
stenosis of approximately 60%. The 9-month scan showed
an increase in its severity, with stenosis of 70% and 3
months later, there was a further increase, with a stenosis of
90%. The degree of stenosis was calculated using the inter-
nal carotid artery to common carotid artery (ICA:CCA)
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1220ratio. The stent was therefore removed surgically with a
carotid endarterectomy without complication.
A retrospective analysis was therefore performed with
the hypothesis that carotid stent fractures are common. The
aims of this study were to determine the prevalence of stent
fractures, the risk factors for fracturing and whether the
presence of a fracture carries any clinical significance.
METHODS
Patients from one surgeon’s practice who had carotid
stenosis deemed suitable for intervention (80% asymp-
tomatic, 70% symptomatic, 50% to 70% if an ulcerated
lesion) and had suitable aortic and carotid morphology for
carotid stenting (appropriate access vessels, type I, II, and
III arches except type III arches with a stenosis of the
brachiocephalic or carotid orifice) between March 2004
and December 2006 were included. T o enhance the qual-
ity of the measurement, two vascular surgeons and one
radiologist examined the x-rays independently to deter-
mine if there was a fracture present. Given that this was a
retrospective study, there was no preconceived sample
size determined.
CAS was performed in the angiography suite, with an
anesthetist present. Under local anesthesia, with minimal or
no conscious sedation, percutaneous access was obtained
using a Seldinger technique in the right common femoral
artery, or rarely, through the left common femoral artery.
Aspirin (100 mg/d) and clopidogrel were started 3 days
before the procedure if the patient was not already taking it.
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months), together with aspirin (100 mg/d indefinitely).
Patients received 5000 units of heparin intravenously in
total, which was administered during the diagnostic por-
tion of the procedure. Blood pressure and electrocardio-
gram were monitored continuously. Thoracic arch aortog-
raphy with angiography of the extracranial and intracranial
carotid arterial tree was done routinely with lateral and
anteroposterior views. A cerebral protection device was
used in all cases and positioned a suitable distance beyond
the distal end of the stenosis. Stenosis and vessel measure-
ments were calculated using the North American Symp-
tomatic Carotid Endarterectomy Trial (NASCET) criteria
of minimal luminal diameter compared with the distal
internal carotid artery diameter and lesions were predilated
with a 2 or 3 mm balloon. The sizing of the stent was
calculated by computer software, and oversizing of the
stent was 1 to 2 mm greater than the ICA diameter, except
if the CCA was large, then no oversizing was included.
Self-expandable stents were deployed and postdilated with
a balloon diameter that was calculated by computer soft-
ware, and never greater than 5 mm. This was to prevent
plaque protrusion through the stent struts with potential
subsequent embolus, and also it was felt that the self-
expanding nitinol stents were able to exert sufficient
chronic outward force to negate the need for using a
balloon more than 5 mm in diameter. Completion ipsilat-
eral selective carotid (extracranial and intracranial) angio-
grams were obtained, and a residual stenosis of 20% was
accepted to be technically satisfactory. Patients were trans-
ferred to the intensive care unit for neurovascular observa-
tion for 24 hours, and no heparin reversal was performed.
Carotid duplex scan was performed at 1, 3, and 6 months,
and yearly thereafter. After the discovery of stent restenosis
with concomitant fracture in the index case, high-resolu-
tion digital images of plain radiographs were organized for
all patients who underwent this procedure. Subsequent
ultrasounds were performed every 6 months for detected
fractures, and other stents continue to be under surveil-
lance with plain films every 6 months. Stent restenosis was
defined as more than 50% diameter reduction or the pres-
ence of occlusion. Widely accepted criteria for the interpre-
tation of restenosis of a carotid stent are yet to be set in the
published literature; a peak systolic velocity ratio (intras-
tent/prestenotic) of greater than or equal to 2.0 was con-
sidered to be indicative of a restenosis of more than 50%
diameter reduction, using the duplex ultrasound criteria for
grading carotid stent stenosis of Zwiebel from the Univer-
sity of South Florida.5
Statistical analysis. All analysis was performed using
SAS version 8.2 (SAS Institute Inc, Cary, NC, USA).
Comparisons of proportions were made using 2 tests for
equal proportion or Fisher exact tests where numbers are
small. A two-sided P value of .05 was considered to be
statistically significant.
Fracture classification. A Nitinol stent fracture classi-
fication has been proposed by the Cardiovascular Institute
of the South (CIS) for Nitinol stent fracture standardiza-tion,6 which can be applicable to carotid stents. Type I
fractures involve a single strut fracture only (Fig 1), type II
fractures involve multiple Nitinol stent fractures that can
occur at different sites (Fig 2), type III fractures involve
multiple Nitinol stent fractures resulting in a complete
transverse linear fracture but without stent displacement
(Fig 3), and type IV fractures have a complete transverse
linear fracture with stent displacement (Fig 4).
RESULTS
Patient demographic details. Sixty-one carotid arter-
ies were treated in 54 patients. Eleven patients were lost to
follow-up (two patients had bilateral stents, and nine pa-
tients had a unilateral stent), leaving a total of 48 stents in
43 patients. Patient demographic details and comorbid
conditions are displayed in Table I. High resolution digital
images were obtained and specific coned views of the stents
were requested. Where possible, the carotid stent was placed
parallel to the x-ray receptor, with an antero-posterior and
lateral views obtained. It was requested that cervical vertebrae
be excluded from the line of projection, however, this was
Fig 1. Type I fracture (arrow). This was an XAct 7-9 mm 
40 mm stent placed in a 74-year-old male. Note the presence of
adjacent calcification.not always adhered to. Despite this, the quality of the
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examiners to detect a fracture.
Primary atherosclerotic lesions were treated in 41 pa-
tients and recurrent stenosis after previous CEA in two (7%)
patients. A history of stroke was present in three (7%)
patients and previous transient ischemic attacks or amauro-
sis fugax in 21 (49%) patients. Nineteen (44%) had asymp-
tomatic disease. Technical success was achieved in 48 cases.
Five out of 48 patients experienced morbidity associated
with the procedure; one retroperitoneal bleed required
operative intervention, two patients suffered a transient
ischemic attack (which resolved completely in 12 hours),
and one patient suffered a stroke with residual disability.
One patient died from myocardial infarction on postoper-
ative day ten.
In this series of 48 carotid artery stents, 29% (n 14) of
the carotid stents implanted had a fracture detected on
follow-up plain radiography (Table II). The mean time to
plain radiographs was 18months (range 4.0 to 37months).
Only a single stent was used in each procedure using one of
Fig 2. Type II fracture. The presence of two or more fractures,
with obvious discontinuity of the stent margin (arrows). This is a
Precise 8 mm  40 mm stent placed in a 76-year-old female. The
adjacent calcification is causing an obvious lateral displacement of
part of the stent (large arrow).three stent types: Xact (Abbott, Abbott Park, Ill), Precise(Cordis, Miami Lakes, Fla), or Exponent (Medtronic Vas-
cular, Santa Rosa, Calif). The same surgeon performed the
procedure in all cases.
Out of the 48 stents implanted, 14 (29%) had a fracture
detected at a mean radiographic follow-up of 18 months.
Duplex sonography was performed in all patients to assess
stent patency. Three out of the 14 fractures showed
increased velocity ratios 2.0. (Table III). The mean
follow-up period for duplex scans was 14.0 months.
Table IV illustrates the velocities on ultrasound accord-
ing to fracture type. (Table IV).
In determining the risk factors for fracture, the pres-
ence of local calcification in the area where the stent was
deployed was examined. Eight out of the 14 fractured
stents were associated with local calcification in the region
of the deployed stent (examples of which are shown in Figs
1 to 3), whereas five out of the 34 stents without a fracture
had localized calcification. The presence of calcification
resulted in a 7.7 times greater odds for a fractured stent
(odds ratio 7.7; standard error 5.6; 95% confidence interval
1.9-32.0). The 2 P  .003. (Table V). The presence of
Fig 3. Type III fracture. Transverse linear fracture without stent
displacement (arrow). This is an Xact 8-10 mm  40 mm stent
placed in a 82-year-old male. Note the localized calcification.angulation of more than 45 degrees in the stented segment
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statistically significant affect on the presence of fractures.
There was no statistically significant association be-
tween fractures and smoking, hypertension, diabetes mel-
Fig 4. Type IV fracture. Transverse linear fracture with stent
displacement (arrow). This is an Xact 8-10 mm 40mm placed in
a 76-year-old male.
Table I. Patient demographics
Number (%)
Mean age (y) 74
Male/female 37 (86)/6 (14)
Smoking 24 (56)
Hypertension 34 (79)
Diabetes mellitus 13 (30)
IHD 22 (51)
Asymptomatic 19 (44)
TIA or amaurosis fugax 21 (49)
Stroke 3 (7)
Bilateral carotid stent 5 (12)
Contralateral occlusion 4 (9)
Ipsilateral previous CEA 2 (5)
IHD, Ischemic heart disease (angina, acute myocardial infarction, coronary
artery bypass graft, percutaneous transluminal coronary angioplasty); TIA,
transient ischemic attack; CEA, carotid endarterectomy.litus or sex of the patient, and amultivariate analysis was notfeasible due to the small numbers in this study. Regarding
the type of stent used 8 out of 34 (24%) of Xact stents, 4 out
of 11 (36%) Precise stents and 2 out of 3 (66%) Exponent
stents had a fracture detected. There was a trend towards
fractures occurring more frequently in the longer stents,
however, this was not statistically significant (P . 28).
The location of the fracture has been categorized into
occurring in the lower, middle or upper third of the stent. It
is difficult to categorize the location of the fractures in
relation to its anatomical location such as the ICA, carotid
bulb, or CCA, given that these fractures are seen on plain
x-rays. Most fractures were located in the middle third.
(Table VI).
DISCUSSION
Stent fracture is not a new phenomenon. Reports of
Table II. Fracture prevalence (mean radiographic follow-
up of 18 months)
Type I Type II Type III Type IV
3 (21%) 6 (43%) 3 (21%) 2 (14%)
Table III. Fracture effect on restenosis
Fractured (n  14) No fracture (n  34)
No restenosis Restenosis No restenosis Restenosis
11 (79%) 3 (21%) 31 (91%) 3 (9%)
Table IV. Results of follow-up duplex scansa
Peak systolic velocity (cm/s) Type I Type II Type III Type IV
150 1 6 1 2
150-300 2 0 1 0
300 0 0 1 0
Total 3 6 3 2
aUsing duplex ultrasound criteria for grading carotid stent stenosis from
University of South Florida.







Calcification 7.7 5.6 1.9-32.0 .003
Angulation 3 2.4 0.6-14.3 .21
Table VI. Fracture location
Lower third Middle third Upper third
1 (9.1%) 6 (54.5%) 4 (36.4%)fracture are noted in Nitinol stents implanted in the periph-
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renal, iliac, popliteal and subclavian, and brachiocephalic
vessels.7-18 The complication of a Nitinol carotid stent
fracture has only been reported as a case study involving the
index case of this surgeon’s series.4
This series has demonstrated that the presence of calci-
fication in the internal carotid artery has a strong associa-
tion with the occurrence of fractures in the stent; a calcified
internal carotid artery is eight times more likely to have a
fracture. Currently in the literature, there is no classification
for the severity of calcification of the carotid artery. As a
consequence, the statement of a calcified vessel in this series
is purely a qualitative statement, referring to the presence of
visible calcium seen on plain radiographs in the region of
the implanted stent. The authors speculate that the pres-
ence of calcification exerts an external loading force on the
stent, which given the irregularity of such plaques, places
focal pressure on certain parts of a stent in situ; this would
be exacerbated by neck movements. A calcified vessel also
creates a more rigid artery and, hence, a point of fixation on
a stent in situ, necessitating that the proximal and distal
unstented segments of artery accommodate for changes in
neck movement. This creates regional friction and, hence,
increases the risk of fracture.
Although not demonstrated with statistical significance
in this series, the presence of angulation, particularly of the
distal internal carotid artery may also have an association
with fracturing of the stent. Flors Vos et al19 used three-
dimensional time-of-flight magnetic resonance angiogra-
phy to determine the effect of head movement on in situ
carotid stents. They found that following CAS, the carotid
artery loses its natural flexion/extension and rotational
flexibility. Furthermore, the ex vivo flexibility properties of
the stents themselves are lost when placed in vivo. As a
result, the stented segment of the artery appears as a stiff,
inflexible unit in all head positions, leaving the unstented
segments to accommodate head movements and resulting
in sharp angulations of up to 85 degrees at the junctions
between the stent and artery.
Furthermore, they found that the CCA and ICA are
subjected to considerable torsion shear with head turning.
In addition to this, there is also a physiological tendency for
these vessels to twist around each other due to the differ-
ences in outflow resistance between the internal and exter-
nal carotid arteries, creating a further torque and shear
force. All of these shear forces lead to friction at both ends
of the stent, placing ongoing stress on the stent and hence
can possibly be a contributing cause to fracture.
All four fracture types were detected in this series, with
type II being the most prevalent. The development of these
fractures may be initiated right at the beginning of the stent
manufacturing process; Nitinol stents must undergo mul-
tiple heat treatments, laser cutting, etching, electropolish-
ing, surface finishing, and fatigue testing.20 Microscopic
investigations show that the strut surface can develop small
microcracks on the surface of the struts, which naturally will
progress when exposed to other forces when in situ.Also, due to its configuration at thermal conditioning,
once the stent is implanted into body temperature, it un-
dergoes a small negative dilation21 of less than 1%, which
according to Stankiewicz, may increase the tensile stresses
developed ahead of a crack and result in decreased fracture
toughness and fatigue-crack growth resistance.
The design of the stent may substantially influence the
likelihood of fractures.22-23 In our series, all three of the
stents used had fractures detected, but further analysis is
limited by the small study size. In the femoral stenting in
obstructions (FESTO) study, Scheinert et al found that
stent design affected the frequency and severity of stent
fractures.
Many stents are designed to withstand a straight cyclic
fatigue stress, which in vivo, does not exist. This is because
the stent in vivo is subject to deformation from multiaxial
sources relating to the effect of the body on the stent and
the stent on the body. In an attempt to increase the
conformability and flexibility of carotid stents, manufactur-
ers have tried to decrease the number of bridges between
rings, and vary the shape of these bridges, employing
non-straight bridges to improve flexibility. However, the
smaller number of connections of these open cell designs
are prone to compression and elongation, contributing to a
higher likelihood of fracture.24 On the contrary, closed cell
stent designs employ a dense scaffolding to create a more
rigid but less flexible stent, increasing its strength but also
its brittleness. The latter may lead to fracture when exposed
to various biomechanical forces such as external compres-
sion. The carotid bifurcation is not protected by the axial
skeleton or skull, and is easily exposed to such external
forces.
The stent durability is also influenced largely by the
physiological loading that it must withstand. After only 30
days in vivo, the carotid stent has faced about 3 million
pulsatile cardiac cycles. Fracture rates of up to 30% have
been reported in stents that are in great vessels close to the
heart.11 Further, the cardiac cycle imparts in vivo cyclic
stresses through continued expansion and contraction of
the carotid arteries. In addition, the ICA is a dynamic
free-floating vessel, being only tethered at the proximal and
distal ends. High velocity flow rates in the carotid arteries
would lend to greater movement of the “free-floating”
vessel, causing greater elongation and contraction of the
vessel and possibly contribute to stent fracture.
Clinical relevance. Although this series of carotid
arterial stent fractures had a fracture rate of 30%, the
majority were benign at time of writing; only three of
these had restenosis 50% on surveillance ultrasound
scans at an average of 12 months postimplantation.
High-grade (75% diameter reduction) after CAS and
CEA is generally thought to be a clinically significant
lesion that can progress to a stroke.25
It is interesting to note that the type IV fractures, which
by definition are displaced, did not have restenosis detected
at average follow-up in this series. It was a type III fracture
that required surgical removal, having progressed rapidly
over 6 months from a 60% stenosis to a 90% stenosis.
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small series, it does nevertheless demonstrate that not all
fractures are benign and can progress to a clinically signifi-
cant stenosis.
A review of the existing Nitinol stent fracture literature
including that for aortic endografts, popliteal arteries, and
coronary stenting (Allie et al6) has consistently described
clinical sequelae related to the fracture in all reports. Moti-
vated by the unclear impact of the phenomenon of stent
fractures in the sirolimus-coated cordis self-expandable
stent (SIROCCO) trial, Scheinert22 initiated the FESTO
study. He found that stent fractures were associated with
restenosis of 50% in one third of fractures, and reocclu-
sion in another third. Clearly, primary patency rate of the
stented segment was significantly lower for patients with
stent fractures (41.1% vs 84.3%, P .00001), demonstrat-
ing its clinical importance and relevance.
Whether the long-term patency of carotid artery stent-
ing is better than the natural history of the disease and/or
surgical endarterectomy is yet to be determined. The clin-
ical impact of carotid stent fractures should not be under-
estimated, especially given the evidence of poor patency of
fractures in the superficial femoral artery stents. This is
exemplified by the concern that the American Food and
Drug Administration has displayed, having mandated ag-
gressive surveillance for stent fractures in all prospective
stent-based device trials.
The question is then raised about when a lesion should
receive intervention if a restenosis is detected. Lal et al26
recommend intervention in asymptomatic lesions80% in
carotid restenosis, reasoning that it is difficult to discern
which lesion will remain asymptomatic. As an aside, Lal
et al report an in-stent restenosis of 80% in five out of
22 (23%) patients in their series, which was diagnosed by
surveillance ultrasonography at 15 months. It would be
interesting to determine the prevalence of carotid stent
fractures in that series.
Limitations. The sensitivity and specificity of plain
radiography in detecting all types of stent fractures is un-
known, even with magnified views. Thus, the potential for
missing possible fractures is present, even though the films
were examined by three independent observers. Fluoros-
copy carries significant risks, and the value of CT angiogra-
phy and ultrasonography likewise is yet to be determined.
In relation to the presence of calcification, analysis is
limited by the qualitative description of calcification being
either present or absent in the region of where the stent is
deployed. A prospective trial would be required to use an
imaging modality such as CT angiography to accurately
quantify the location and severity of calcification, including
whether it is circumferential or localized.
There are also limitations due to the type of study being
a single centre, retrospective, nonrandomized case-control
study. Eleven out of 54 patients were lost to follow-up,
which may have an impact on the accuracy of the analysis of
complications in this series given that it represents twenty
percent of the study size.Furthermore, the ability to draw conclusions regarding
risk factors for fracturing, and long term sequelae is limited
by the small sample size of this series (which precluded a
multivariate analysis) and short follow-up period for ultra-
sonography. Nevertheless, the objective of this article was
to inform clinicians of a potential complication of carotid
stenting and recommend continued long-term surveil-
lance.
CONCLUSION
Not all carotid stent fractures are benign. The authors
believe it is worthwhile to include plain radiographs in
addition to the regular surveillance of carotid stents with
duplex ultrasonography to enable early detection of frac-
turing and, hence, institution of any appropriate interven-
tion to aid in the prevention of sequelae such as recurrent
stenosis, should it become apparent. The latter is ever more
so important in the carotid artery, which has little room for
error, if any at all.
AUTHOR CONTRIBUTIONS
Conception and design: AL, KS
Analysis and interpretation: AL
Data collection: AL, TG
Writing the article: AL, TG
Critical revision of the article: AL, KS, PM, TG
Final approval of the article: KS, PM
Statistical analysis: AL
Obtained funding: AL, PM
Overall responsibility: KS
REFERENCES
1. North American Symptomatic Carotid Endarterectomy Trial Collab-
orators. Beneficial effect of carotid endarterectomy in symptomatic
patients with high-grade carotid stenosis. N Engl J Med 1991;325:
445-53.
2. Executive Committee for the Asymptomatic Carotid Atherosclerosis
Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA
1995;273:1421-8.
3. European Carotid Surgery Trial Investigators. Randomized trial of
endarterectomy for recently symptomatic carotid stenosis: final results
of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;
351:1379-87.
4. Valibhoy AR, Mwipatayi BP, Sieunarine K. Fracture of a carotid stent:
an unexpected complication. J Vasc Surg 2007;45:603-6.
5. Armstrong PA, Bandyk DF, Johnson BL, Back MR, Shames ML,
Zwiebel BR. Duplex scan surveillance after carotid angioplasty and
stenting: a rational definition of stent stenosis. J Vasc Surg 2007;46:
460-5.
6. Allie DE, Hebert CJ, Walker CM. Nitinol stent fractures in the SFA.
Endovascular Today July/August 2004, 22-34.
7. Schoefl R, Winkelbauer F, Haefner M, Poetzi R, Gangl A, Lammer J.
Two cases of fractured esophageal Nitinol stents. Endoscopy 1996;28:
518-20.
8. Peck R,Wattman J. Fracture of memothermmetallic stents in the biliary
tract. Cardiovasc Intervent Radiol 2000;23:55-6.
9. Suzuki N, Saunders BP, Thomas-Gibson S, Marshall M, Halligan S,
Northover JM. Complications of colonic stenting: a case of stent
migration and fracture. Endoscopy 2003;35:1085.
10. Makaryus AN, Leftkowitz L, Lee AD. Coronary artery stent fracture.
Int J Cardiovasc Intervent 2007;23:305-9.
11. Knirsch W, Haas NA, Lewin MA, Uhlemann F. Longitudinal stent
fracture 11 months after implementation in the left pulmonary artery
JOURNAL OF VASCULAR SURGERY
June 20081226 Clairand successful management by a stent-in-stent maneuver. Cathet
Cardiovasc Intervent 2003;58:116-8.
12. Mehrle A, Skelton T, Almonacid A. Stent fracture: an unusual cause of
late restenosis after sirolimus-eluting stent placement. Catheter Cardio-
vasc Intervent 2007;69:989-92.
13. Sianos G, Hofma S, Ligthart J, Saia F, Hoye A, Lemos PA, et al. Stent
fracture and restenosis in the drug-eluting stent era. Catheter Cardio-
vasc Intervent 2004;61:111-6.
14. Bessias N, Sfyroeras G, Moulakakis KG, Karakasis F, Ferentinou E,
Andrikopoulos V. Renal artery thrombosis caused by stent fracture in a
single kidney patient. J Endovasc Ther 2005;12:516-20.
15. Sacks BA, Miler A, Gottlieb M. Fracture of an iliac artery Palmaz stent.
J Vasc Intervent Radiol 1996;7:53-5.
16. Babalik E, Gulbaran M, Gurmen T, Ozturk S. Fracture of popliteal
artery stents. Circ J 2003;67:643-5.
17. Phipp LH, Scott DJ, Kessel D, Robertson I. Subclavian stents and stent
grafts: cause for concern? J Endovasc Surg 1999;6:223-6.
18. Wada M, Yamamoto M, Shiba M, Tsuji T, Iijima R, Nakajima R, et al.
Stent fracture in the left brachiocephalic vein. Cardiovasc Revasc Med
2007;8:103-6.
19. Floris Vos AW, Linsen MA, Marcus T, van den Berg JC, Vos J, Rauweda
JA, et al. Carotid artery dynamics during head movements: a reason for
concern with regard to carotid stenting? J Endovasc Ther 2003;10:862-9.
doi:10.1016/j.jvs.2008.01.04420. Robertson SW, Ritchie RO. In vitro fatigue-crack growth and fracture
toughness behavior of thin-walled superelastic Nitinol tube for endo-
vascular stents: A basis for defining the effect of crack-like defects.
Biomaterials 2007;28:700-9.
21. Stankiewicz JM, Robertson SW, Ritchie RO. Fatigue-crack growth
properties of thin-walled superelastic austenitic Nitinol tube for endo-
vascular stents. J Biomed Mater Res A 2007;81:685-91.
22. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlick S, Ulrich M,
et al. Prevalence and clinical impact of stent fractures after femoropop-
liteal stenting. J Am Coll Cardiol 2005;45:312-5.
23. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W,
et al. Balloon angioplasty versus implantation of Nitinol stents in the
superficial femoral artery. New Eng J Med 2006;354:1879-90.
24. Bosiers M, Deloose K, Nerbist J, Peeters P. Review of stents for the
carotid artery. J Cardiovasc Surg 2006;47:107-13.
25. Cakhtoura EY, Hobson RW, Goldstein J, Simonian GT, Lai BK, Haser
PB, et al. In-stent restenosis after carotid angioplasty-stenting: inci-
dence and management. J Vasc Surg 2001;33:220-5.
26. Lal BK, Hobson RW 2nd, Goldstein J, Geohagan M, Chakhtoura E,
Pappas PJ, et al. In-stent recurrent stenosis after carotid artery stenting:
life table analysis and clinical relevance. J Vasc Surg 2003 Dec;38:
1162-8.Submitted Sep 30, 2007; accepted Jan 3, 2008.INVITED COMMENTARYDaniel G. Clair, MD, Cleveland, Ohio
Stent fracture is something that has been identified in nearly
every region in which stents have been implanted. In particular, the
use of stents within the vascular system has increased dramatically
over the past 10 years. It is only with extended use and evaluation
that identification of stent fractures within the superficial femoral
artery was recognized. These stent fractures have been associated
with extended lengths of treatment, extensive calcification of the
vessels, and an increased incidence of re-stenosis within the vessels.
To date, no extensive evaluation of stents within the carotid
distribution has been performed until the present study.
This study in particular brings out several important points.
The first of these is that the incidence of stent fractures within the
carotid distribution is likely higher than previously expected. Sec-
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Copyright © 2008 by The Society for Vascular Surgery.ondly, calcification within the internal carotid artery radically in-
creases the risk of stent fracture and third, there is yet an undeter-
mined relationship between stent fracture and recurrent stenosis
within the carotid artery. Several other points deserve emphasis as
well.
Despite the fact that only a short segment of the carotid artery
is treated with these stents, a significant percentage of these stents
fractured. Second, although these stents involve modifications of
existing stents, the modifications made to accommodate the anat-
omy of the carotid circulation are inadequate to completely allevi-
ate the risks of stent fracture and to accommodate the increased
motion noted in this vascular region.
The findings of this current study present yet another note of
caution for those treating the carotid artery with interventional
means. These findings also point out the importance of the need
for further studies to evaluate the short-term and long-term func-
tion of interventional therapy in carotid bifurcation disease.
